Site Sourcing, Procurement, and Study Start-Up
30-40% cost savings compared to traditional CROs, with site activation in < 90 days, and over 200 cancer centers in 28 countries on speed dial!
Welcome to the WINNIEDEL Difference
Early-phase oncology that’s fast, frank, and relationship-driven.
-
200-plus pre-vetted cancer centers in 28 countries—plus niche sites outside the panel when your protocol demands it.
-
SSU Essential documents, FQ, CTA, budget, IB, etc, and everything under the SSU umbrella. CDAs are already in place. Waiting is for airlines, not SSUs.
-
Skip the generic ‘groundhog day’ boilerplate and ask what actually matters to your indication. Our sites answer faster because we’ve known them longer, and you get to decide faster.
-
Proven in early phase trials under the cancer umbrella. Variables (phase, therapeutic indication, site workloads/attrition) can shift days, but the benchmark holds.
-
Decade-long relationships with KOLs, PIs and administrators remove redundant approvals and “who-are-you?” delays.
We Help You Cut Through The Noise
WINNIEDEL’s play is simple: leverage the trust we’ve earned on both sides of the table. Our sponsors receive unfiltered intel and transparent timelines; our sites understand that the ask is genuine and the protocol aligns with their patients' needs. Because everyone already trusts the messenger, signatures move instead of stalling. The result? A clean sprint from award to First-Patient-In, without the logistical gridlock that sinks most early-phase oncology trials.
Ready to Start-Up?
We’re here to help you skip the fluff while maintaining momentum. Get in touch to see how a network built on real relationships and a firm “no-BS” policy gets treatment options to patients faster.